Gts Securities LLC Bio N Tech Se Transaction History
Gts Securities LLC
- $2.05 Trillion
- Q4 2024
A detailed history of Gts Securities LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Gts Securities LLC holds 1,937 shares of BNTX stock, worth $228,333. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,937
Previous 38,800
95.01%
Holding current value
$228,333
Previous $4.61 Million
4689.95%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$969 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$519 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$506 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...